91 related articles for article (PubMed ID: 9483755)
21. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
22. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
Reh A; Oktem O; Oktay K
Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
[TBL] [Abstract][Full Text] [Related]
23. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
[TBL] [Abstract][Full Text] [Related]
24. First-line treatment of Hodgkin's lymphoma.
Klimm B; Engert A; Diehl V
Curr Hematol Rep; 2005 Jan; 4(1):15-22. PubMed ID: 15610655
[TBL] [Abstract][Full Text] [Related]
25. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
Blumenfeld Z; von Wolff M
Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
[TBL] [Abstract][Full Text] [Related]
26. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
27. Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
Klimm B; Reineke T; Haverkamp H; Behringer K; Eich HT; Josting A; Pfistner B; Diehl V; Engert A;
J Clin Oncol; 2005 Nov; 23(31):8003-11. PubMed ID: 16204002
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
Zhou L; Wang Q; Feng F
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):333-5. PubMed ID: 11778565
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
[TBL] [Abstract][Full Text] [Related]
30. [What is your diagnosis? Relative hypergonadotrophic ovarian insufficiency after chemotherapy for Hodgkin disease].
Zanetti Dällenbach R; De Geyter C
Praxis (Bern 1994); 2001 Jan; 90(3):47-9. PubMed ID: 11219206
[No Abstract] [Full Text] [Related]
31. Hypothermia following chemotherapy for Hodgkin's disease.
Weens JH; Hernandez B
Cancer Treat Rep; 1986 Feb; 70(2):313-4. PubMed ID: 3948197
[No Abstract] [Full Text] [Related]
32. Optimal treatment of premature ovarian failure after treatment for Hodgkin's lymphoma is often withheld.
Verschuuren SI; Schaap JJ; Veer MB; Stijnen T; Burger CW; Ansink AC
Acta Obstet Gynecol Scand; 2006; 85(8):997-1002. PubMed ID: 16862482
[TBL] [Abstract][Full Text] [Related]
33. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
[TBL] [Abstract][Full Text] [Related]
34. Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Brosteanu O; Hasenclever D; Loeffler M; Diehl V;
Ann Hematol; 2004 Mar; 83(3):176-82. PubMed ID: 15064867
[TBL] [Abstract][Full Text] [Related]
35. [Secondary breast cancer after treatment for Hodgkin's disease. About seven cases].
Ben Hassouna J; Slimène M; Boussen H; Bouzaiene H; Khomsi F; Chargui R; Kochbati L; Mtaallah MH; Gamoudi A; Benna F; Hechiche M; Rahal K
Gynecol Obstet Fertil; 2007 Jun; 35(6):536-40. PubMed ID: 17543568
[TBL] [Abstract][Full Text] [Related]
36. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201
[TBL] [Abstract][Full Text] [Related]
38. [Nephrotic syndrome in Hodgkin's disease].
Miltényi Z; Keresztes K; Ujhelyi L; Kovács J; Illés A
Orv Hetil; 2005 Jun; 146(25):1357-60. PubMed ID: 16106759
[TBL] [Abstract][Full Text] [Related]
39. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
Aurlien E; Holte H; Pharo A; Kvaløy S; Jakobsen E; Smeland EB; Kvalheim G
Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
